IRF2BP2 was sequenced to determine the coding exons by pyrosequencing, and somatic variations (nonsense mutations) were found in 14% of the PCNSL cases (Bruno et al., 2014). This evidence concerns the gene IRF2BP2 and primary central nervous system lymphoma.